MATERIALS AND METHODS

Preparation of Traditional Medicine Samples
Information on antimalarial and antipyretic therapies was collected through traditional healers and research on "Dong-yibo-gam" written by J. Hur in the Chosun dynasty. 4) Solanum nigrum, Artemisia capillaris, Kalopanax pictus, Scutellaria baicalensis, Coptis japonica, and Phellodendron amurense were purchased from the oriental drug store, Bohwa Dang (Chunju, South Korea). The traditional medicines (100 g) were extracted with distilled water (500 ml) at 70°C for 5 h. The extract was filtered through a 0.45-mm filter, lyophilized, and kept at 4°C. The yield of dried extract (black color) from starting crude materials was about 8.9% (w/w). The dried extract was dissolved in water before use. Quinine hydrochloride, a clinically used antimalarial drug, was from Sigma (St. Louis, MO, U.S.A.), Malaria Parasites P. falciparum (ATCC 30932, FCR-3 strain) was used in our study. P. falciparum was cultivated by a modification of the method of Trager and Jensen 5) using a 5% hematocrit of type A human red blood cells suspended in RPMI 1640 medium (Gibco, NY, U.S.A.), and supplemented with heat-inactivated 10% type A human serum. The plates were placed in a CO 2 -O 2 -N 2 incubator (5% CO 2 , 5% O 2 , and 90% N 2 atmosphere) at 37°C, and the medium was changed daily until 5% parasitemia (which means the existence of 5 parasite-infected erythrocytes in every 100 erythrocytes).
Mammalian Cells Mouse mammary tumor FM3A cells (wild-type, subclone F28-7) 6) were supplied by the Japanese Cancer Research Resources Bank (JCRB). FM3A cells were maintained in a suspension culture at 37°C in a 5% CO 2 atmosphere in plastic bottles containing ES medium (Nissui Pharmaceuticals, Tokyo, Japan) supplemented with 2% heatinactivated fetal bovine serum (Gibco, NY, U.S.A.).
In Vitro Antimalarial Activity of Traditional Medicines The following procedures were used to assay antimalarial activity. 7, 8) Asynchronously cultivated P. falciparum was used. Various concentrations of compounds in distilled water were prepared. Ten microliters of each solution was added to individual wells of a 24-well multi-dish.
Erythrocytes with 0.3% parasitemia were added to each well containing 990 ml of culture medium to give a final hematocrit level of 3%. The plates were incubated at 37°C for 72 h in a multigas incubator (5% CO 2 , 5% O 2 , and 90% N 2 atmosphere). To evaluate the antimalarial activity of traditional medicines, we prepared thin blood films from each culture and stained them with Giemsa (Merck, Germany). A total of 10000 erythrocytes per one thin blood film were examined under microscopy. All of the test compounds were assayed in duplicate at each concentration. Drug-free control cultures were run simultaneously. All data points represent the mean of three experiments. Parasitemia in the control reached between 4 and 5% at 72 h. The EC 50 value refers to the concentration of the compound necessary to inhibit the increase in parasite density at 72 h by 50% of the control.
Toxicity against Mammalian Cell Line FM3A cells grew with a doubling time of about 12 h. Prior to exposure to drugs, the cell density was adjusted to 5ϫ10 4 cells/ml. A cell suspension of 990 ml was dispensed to the test plate, and the compound at various concentrations suspended in distilled water (10 ml) was added to individual wells in the 24-well multi-dish. The plates were incubated at 37°C in a 5% CO 2 atmosphere for 48 h. All of the test compounds were assayed in duplicate at each concentration. Cell numbers were measured using a cell counter CC-130 (Toa Medical Electric Co., Japan). All data points represent the mean of three experiments. The EC 50 value refers to the concentration of the compound necessary to inhibit by 50% the increase in cell density of the control at 48 h. Selectivity refers to the mean of the EC 50 value for FM3A cells per the mean of the EC 50 value for P. falciparum.
RESULTS AND DISCUSSION
Six aqueous extracts of herbal medicine used for malarial and antipyretic therapies in Korea were assessed for their antimalarial activities. The results of the in vitro antimalarial activity and cytotoxicity of the extracts against P. falciparum and mammalian cells are summarized in Table 1 . The extracts of C. japonica showed high antimalarial activity (EC 50 ϭ 1.4 mg/ml), but it had no selective toxicity (selectivityϭ1). Five other extracts showed evident antimalarial activity with EC 50 values ranging from 3.5 to 8.1 mg/ml, and exhibiting greater than 2 times the selective activities. In addition, K. pictus had moderate antimalarial activity (EC 50 ϭ4.6 mg/ml) with no cytotoxicity for mammalian cells treated at 20.0 mg/ml, and weak antimalarial activity relative to quinine (EC 50 ϭ0.05 mg/ml against P. falciparum). The stage specific effect of K. pictus was determined on the parasite-infected erythrocytes. K. pictus showed morphological changes of the parasites at the transition from trophozoites to the schizont stages (data not shown).
This is the first report on antimalarial activities of herbal medicine traditionally used for malaria and antipyretic therapy in Korea, and all extracts in this study showed antimalarial activities. In particular, the extract of K. pictus revealed antimalarial activity with no cytotoxicity in vitro. Our results indicate that Korean traditional medicine would be promising for further investigation for new antimalarial agents. a) Selectivity refers to the ratio of the EC 50 value for the FM3A cells and the EC 50 value for P. falciparum. b) The value in parenthesis shows the growth (%) of each dose.
